Dr. Mark Walberg, M.D.
What this data tells you about Dr. Walberg
Dr. Mark Walberg is a medical oncology in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Walberg performed 69,909 Medicare services across 1,757 unique beneficiaries.
Between the years covered by Open Payments, Dr. Walberg received a total of $581 from 15 pharmaceutical and/or device companies across 28 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Walberg is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 13,400 | $43 | $136 |
| Anti-nausea injection (fosaprepitant) | 12,000 | $0 | $5 |
| Iron infusion (Feraheme) | 7,140 | $0 | $5 |
| Paclitaxel chemotherapy injection | 6,517 | $0 | $8 |
| Nivolumab injection (Opdivo) | 5,940 | $24 | $77 |
| Iron sucrose injection (Venofer) | 5,700 | $0 | $2 |
| Oxaliplatin chemotherapy injection | 4,400 | $0 | $33 |
| Contrast dye for imaging (iodine-based) | 4,209 | $0 | $3 |
| Daratumumab injection (Darzalex) | 3,600 | $38 | $128 |
| Dexamethasone injection (steroid) | 1,862 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,200 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 570 | $0 | $24 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 360 | $23 | $157 |
| Injection, leucovorin calcium, per 50 mg | 328 | $3 | $25 |
| Administration of chemotherapy into vein, 1 hour or less | 278 | $105 | $707 |
| Injection, fluorouracil, 500 mg | 242 | $2 | $13 |
| Injection of additional new drug or substance into vein | 239 | $12 | $108 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 227 | $3 | $373 |
| Injection, carboplatin, 50 mg | 186 | $2 | $300 |
| Injection, magnesium sulfate, per 500 mg | 158 | $1 | $6 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 156 | $68 | $1,348 |
| Injection, zoledronic acid, 1 mg | 117 | $7 | $431 |
| Office visit, established patient (30-39 min) | 95 | $92 | $368 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 90 | $49 | $313 |
| Administration of additional new drug or substance into vein, 1 hour or less | 86 | $52 | $344 |
| Injection, diphenhydramine hcl, up to 50 mg | 84 | $1 | $7 |
| Unclassified drugs | 69 | $1 | $8 |
| Blood draw (venipuncture) | 67 | $8 | $20 |
| Comprehensive metabolic blood panel | 67 | $10 | $64 |
| Complete blood count (CBC) with differential | 56 | $8 | $36 |
| Infusion, normal saline solution , 1000 cc | 51 | $2 | $19 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 50 | $16 | $94 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 50 | $57 | $211 |
| Ct scan of chest with contrast | 41 | $62 | $821 |
| Administration of chemotherapy into vein, each additional hour | 40 | $23 | $161 |
| Hospital follow-up visit, moderate complexity | 36 | $62 | $247 |
| CT scan of abdomen and pelvis with contrast | 34 | $182 | $1,067 |
| Drug injection, under skin or into muscle | 34 | $11 | $96 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 26 | $135 | $500 |
| Infusion into a vein for hydration, each additional hour | 21 | $10 | $75 |
| Administration of additional new drug or substance into vein using push technique | 20 | $44 | $289 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 19 | $16 | $100 |
| Office visit, established patient, complex (40-54 min) | 17 | $121 | $496 |
| CT scan of chest, without contrast | 14 | $53 | $686 |
| Application of on-body injector for under skin injection | 13 | $15 | $96 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Walberg is a mixed practice specialist, with above-average Medicare volume (top 15% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Walberg experienced with pembrolizumab injection (keytruda)?
Does Dr. Walberg receive payments from pharmaceutical companies?
How do Dr. Walberg's costs compare to other medical oncologys in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology